Advances, achievements, and challenges in action to eliminate hepatitis C as a public health threat in China
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 2
Abstract
In 2016, the World Health Organization proposed the vision of eliminating viral hepatitis as a public health threat by 2030, and since then, China has actively promoted the elimination of hepatitis C as a public health threat and has made great achievements by formulating policies, clarifying main tasks, focusing on key issues, and implementing prevention and treatment measures. This article reviews the advances and achievements in China’s actions to eliminate hepatitis C as a public health threat since 2016, analyzes the existing problems and challenges, and puts forward recommendations for future prevention and control strategies, in order to provide a reference for achieving the goal of eliminating viral hepatitis as a public health threat by 2030.
Authors and Affiliations
Jian LI, Zhongfu LIU
Gut microbiota in hepatitis B cirrhosis
Hepatitis B cirrhosis is the most significant component of liver cirrhosis in China, and there is a significant increase in the mortality rate of patients after progression from hepatitis to liver cirrhosis. A large num...
Level of vitamin D in children with cholestatic liver disease and its clinical features
[Objective] To investigate vitamin D level in children with cholestatic liver disease, and to provide a theoretical basis for vitamin D supplementation therapy in children with this disease. [Methods] A total of 116 chi...
Impact of hepatocellular carcinoma on the prognosis of patients with liver cirrhosis undergoing emergency endoscopic therapy due to esophagogastric variceal bleeding
[Objective] To investigate the impact of hepatocellular carcinoma (HCC) on the prognosis of patients with liver cirrhosis undergoing emergency endoscopic therapy for esophagogastric variceal bleeding, as well as indep...
Liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus infection
[Objective] To investigate the liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus (HBV) infection. [Methods] A total of 271 patients with...
Association of TRIM29 with HBV replication and the antiviral effect of pegylated interferon α-2b
[Objective] To preliminarily investigate the association of TRIM29 with HBV replication and the antiviral effect of pegylated interferon α-2b (PEG-IFN-α-2b), since TRIM29 protein is involved in the development and pro...